Monday, March 12, 2018 4:37:23 PM
read from "OWN THE FLOAT.COM" today :
"PAO Group, PAOG also has the same CEO as Rising Biosciences, Robert Weber. This is another stock that falls into the same pattern of trading as I stated in the above paragraph. I feel this company is way undervalued as well with the major progress they have made in treating a variety of diseases with their unique customized approach, but as per the companies mission, mainly geared to opioid addicted therapies. Additionally, their expansion into several legal states with the new corporate owned centers, has lead to sharp increase in revenues reported by the company. The opioid crisis is a major problem that is happening right now in this country and is growing at an alarming rate. POAG has aligned itself in a sector that is not only much needed for this country in battling the opioid addictions, but can be very lucrative as well for shareholders."
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM